Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ujike

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
Clinical Neuropharmacology|January 1, 1985
Effective treatment of pure akinesia with L-threo-3,4-dihydroxyphenylserine (DOPS): report of a case, with pharmacological considerationsM Yamamoto, H Ujike, N Ogawa
Perception|April 21, 1999
Apparent depth with retinal image motion of expansion and contraction yoked to head movementT Yajima, H Ujike, K Uchikawa
Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1987
Taste loss as an initial symptom of primary amyloidosisH Ujike, M Yamamoto, I Hara
Journal of the Neurological Sciences|March 1, 1986
Effect of L-threo-3,4-dihydroxyphenylserine chronic administration on cerebrospinal fluid and plasma free 3-methoxy-4-hydroxy-phenylglycol concentration in patients with Parkinson's diseaseM Yamamoto, N Ogawa, H Ujike
Brain Research|June 21, 1988
Effects of acute and long-term treatment with methamphetamine on substance P concentration and receptor numbers in the rat brainH Ujike, N Ogawa, S Otsuki
Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference|February 3, 2007
Effects of virtual body motion on visually-induced motion sicknessH Ujike, T Yokoi, S Saida
Psychopharmacology|January 1, 1990
D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaineH Ujike, K Akiyama, S Otsuki
Neuroreport|April 10, 1996
[3H]YM-09151-2 (nemonapride), a potent radioligand for both sigma 1 and sigma 2 receptor subtypesH Ujike, K Akiyama, S Kuroda
Rinsho Shinkeigaku = Clinical Neurology|July 1, 1989
[Two siblings of juvenile Parkinson's disease dystonic type (Yokochi type 3) and hereditary progressive dystonia with marked diurnal fluctuation (Segawa)]H Ujike, M Nakashima, S Kuroda, et al.
Life Sciences|January 1, 1992
Supersensitivity of sigma receptors after repeated administration of cocaineH Ujike, K Tsuchida, K Akiyama, et al.
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Clinical Neuropharmacology|January 1, 1985
Effective treatment of pure akinesia with L-threo-3,4-dihydroxyphenylserine (DOPS): report of a case, with pharmacological considerationsM Yamamoto, H Ujike, N Ogawa
Perception|April 21, 1999
Apparent depth with retinal image motion of expansion and contraction yoked to head movementT Yajima, H Ujike, K Uchikawa
Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1987
Taste loss as an initial symptom of primary amyloidosisH Ujike, M Yamamoto, I Hara
Journal of the Neurological Sciences|March 1, 1986
Effect of L-threo-3,4-dihydroxyphenylserine chronic administration on cerebrospinal fluid and plasma free 3-methoxy-4-hydroxy-phenylglycol concentration in patients with Parkinson's diseaseM Yamamoto, N Ogawa, H Ujike
Brain Research|June 21, 1988
Effects of acute and long-term treatment with methamphetamine on substance P concentration and receptor numbers in the rat brainH Ujike, N Ogawa, S Otsuki
Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference|February 3, 2007
Effects of virtual body motion on visually-induced motion sicknessH Ujike, T Yokoi, S Saida
Psychopharmacology|January 1, 1990
D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaineH Ujike, K Akiyama, S Otsuki
Neuroreport|April 10, 1996
[3H]YM-09151-2 (nemonapride), a potent radioligand for both sigma 1 and sigma 2 receptor subtypesH Ujike, K Akiyama, S Kuroda
Rinsho Shinkeigaku = Clinical Neurology|July 1, 1989
[Two siblings of juvenile Parkinson's disease dystonic type (Yokochi type 3) and hereditary progressive dystonia with marked diurnal fluctuation (Segawa)]H Ujike, M Nakashima, S Kuroda, et al.
Life Sciences|January 1, 1992
Supersensitivity of sigma receptors after repeated administration of cocaineH Ujike, K Tsuchida, K Akiyama, et al.
Pageof 11